| |
Centre for Policy on Ageing | |
 | |
|
| The effects of galantamine treatment on caregiver time in Alzheimer's disease | | Author(s) | Mary Sano, Gordon K Wilcock, Bart van Baelen |
| Journal title | International Journal of Geriatric Psychiatry, vol 18, no 10, October 2003 |
| Pages | pp 942-950 |
| Keywords | Dementia ; Drugs ; Informal care ; Self care capacity ; Mobility ; Time duration ; Clinical surveys. |
| Annotation | Caregivers of galantamine-treated patients were more likely to report reductions, maintenance or smaller increases in time assisting with activities of daily living (ADLs) compared with a placebo group. Caregivers of galantamine-treated patients were more likely to report increases, maintenance or smaller reductions in time the patient could be left unsupervised, compared with the placebo. The effects of galantamine treatment were greater among patients with moderate Alzheimer's disease (AD) than among those with mild disease. The clinical benefits of galantamine for patients with AD are also associated with benefits to caregivers. These findings are based on a UK study of 411 patients, in which the Allocation of Time Survey (ACTS) was used as an outcome measure. (RH). |
| Accession Number | CPA-031106206 A |
| Classmark | EA: LLD: P6: CA: C4: 4N: 3G |
Data © Centre for Policy on Ageing |
|
| ...from the Ageinfo database published by Centre for Policy on Ageing. |
| |
|